2023³â Á¦ 26Â÷ ¿µ³² ³»°ú°è ½ÅÀåÀÌ½Ä ¿¬±¸È¸ ¿¬¼ö°Á : 2023-03-25
±³À°ÀÏÀÚ : 2023-03-25
±³À°Àå¼Ò : ¿µ³²´ëÇб³º´¿ø È£Èí±âÀü¹®Áúȯ¼¾ÅÍ ´ë°´ç (·ÎºñÃþ-ÁöÇÏ1Ãþ)
±³À°ÁÖÁ¦ : 2023³â Á¦ 26Â÷ ¿µ³² ³»°ú°è ½ÅÀåÀÌ½Ä ¿¬±¸È¸ ¿¬¼ö°ÁÂ
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ³²³»°ú°è½ÅÀÌ½Ä ¿¬±¸È¸
´ã´çÀÚ : °¼®ÈÖ
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ : ksn@ksn.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-25 ´ë°´ç 14:00~14:25 Prevention and Treatment of posttransplantation diabetes mellitus-Towards a Personalized Approach ¹éÁøÇõ(°è¸íÀÇ´ë)
±³À°½Ã°£ 03-25 ´ë°´ç 14:25~14:50 Glomerulonephritis of the Kidney Allograft-Toward a precision Medicine Approach ±èÅÂÈñ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03-25 ´ë°´ç 14:50~15:15 Emerging strategies for acute Antibody-Mediated Rejection ¾ÈÁ¤¸í(ºÀ»ýº´¿ø)
±³À°½Ã°£ 03-25 ´ë°´ç 15:15~15:40 Tackling chronic Antibody-Mediated Rejection ÀÓÁ¤ÈÆ(°æºÏÀÇ´ë)
ÈÞ½Ä 03-25 ´ë°´ç 15:40~16:00 Break ()
±³À°½Ã°£ 03-25 ´ë°´ç 16:00~16:20 Case 1: BK virus associatted urothelial carcinoma in a Kidney Transplant recipient ÀÌÇöÁ¤(°è¸íÀÇ´ë)
±³À°½Ã°£ 03-25 ´ë°´ç 16:20~16:40 Case 2: A case of progressive decline in renal function after deceased donor kidney transplant ÀÌÁö¿¹(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03-25 ´ë°´ç 16:40~17:00 Case 3: A case of allograft dysfunction after Living donor kidney transplant human leukocyte antigen-identical sibling À̼º¿í(°æºÏÀÇ´ë)
±³À°½Ã°£ 03-25 ´ë°´ç 17:00~17:20 Case 4: Discrepancy between clinical and pathologic findings in a Kidney Transplant recipient ±è¾çÇö(ºÀ»ýº´¿ø)
Åä·Ð 03-25 ´ë°´ç 17:20~17:40 ÁúÀÇ ¹× ÅäÀÇ ±è¾çÇö(ºÀ»ýº´¿ø)